The CEO's $9M open-market buy is a rare and strong insider signal that may indicate management views the post-guidance-cut selloff as overdone. Traders should watch for additional insider buying or a company announcement to confirm the signal before acting.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 10 $50.46entry
- T+1 · 3mo ago +1.45%α +1.77% · $51.19
- T+5 · 3mo ago +1.92%α +1.97% · $51.43
- T+20 · 2mo ago −10.86%α −9.95% · $44.98
- T+60 · 13d ago −13.79%α −11.38% · $43.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider buying at Boston Scientific, led by CEO Michael Mahoney's $9.0M open-market purchase, follows the company's Q2 2026 earnings beat but significantly lowered full-year guidance. The buying is concentrated in the days after the earnings release, suggesting insiders view the post-guidance-cut stock price as undervalued. The total insider buying of $9.33M represents a negligible ~0.013% of the $71.4B market cap, but the CEO's personal $9M purchase is a strong conviction signal that partially offsets the bearish earnings context.
Key Financial Metrics
Key Facts
- CEO Michael Mahoney purchased 186,240 shares for $9.0M in an open-market transaction on 2026-08-03.
- Total insider buying cluster of $9.33M from 3 insiders over a 7-day window.
- Director David Habiger made three small open-market purchases totaling ~$157K.
- The buying follows a Q2 2026 earnings beat (EPS $0.86 vs. $0.83 consensus) but a significant guidance cut (organic growth to 5-6% from 6.5-8%, EPS to $3.28-$3.32 from $3.34-$3.41).
- The $9.33M total buying is ~0.013% of BSX's $71.4B market cap, which is trivial by proportionality standards, but the CEO's $9M personal outlay is a notable signal.
Financial Impact
CEO personally deployed $9.0M of his own capital at ~$48.33/share, representing a strong vote of confidence in the company's valuation post-guidance-cut.
Risk Factors
- The guidance cut signals a material deceleration in the core business that may not be fully priced in.
- The $9.33M buying is only 0.013% of market cap, making it statistically trivial by proportionality standards.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BSX-1786165810451 |
Track record
22 reports on BSX
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.
Filters
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
- Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
- Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
- Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
- Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 5/10 Viewing Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers